PDS Biotechnology Corporation (PDSB) Social Stream
PDS BIOTECHNOLOGY CORP (PDSB) Price Targets From Analysts
Use the tables below to see what analysts covering PDS BIOTECHNOLOGY CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-13 | 5 | $25 | $15 | $20.4 | $5.17 | 294.58% |
| 2022-10-26 | 6 | $25 | $15 | $20.6 | $5.17 | 298.45% |
| 2022-11-01 | 6 | $25 | $10 | $18.833 | $5.17 | 264.27% |
| 2022-11-18 | 6 | $25 | $10 | $18.428 | $5.17 | 256.44% |
| 2022-12-28 | 6 | $25 | $12 | $18.714 | $5.17 | 261.97% |
| 2023-01-03 | 6 | $25 | $12 | $19.571 | $5.17 | 278.55% |
| 2023-03-29 | 5 | $25 | $12 | $20.166 | $5.17 | 290.06% |
| 2023-04-24 | 5 | $25 | $12 | $19.166 | $5.17 | 270.72% |
| 2023-05-16 | 5 | $25 | $12 | $19.8 | $5.17 | 282.98% |
| 2023-08-15 | 5 | $25 | $14 | $20.2 | $5.17 | 290.72% |
| 2023-10-03 | 5 | $25 | $14 | $20 | $5.17 | 286.85% |
| 2023-11-10 | 5 | $25 | $14.001 | $20 | $5.17 | 286.85% |
| 2023-11-15 | 5 | $21 | $14.001 | $18 | $5.17 | 248.16% |
The Trend in the Analyst Price Target
PDSB's average price target has moved down $2.4 over the prior 20 months.
PDSB reports an average of 228.67% for its upside potential over the past 37 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-24 | 5 | 25 | 12.000 | 19.166 | 6.33 | 202.78% |
| 2023-05-30 | 5 | 25 | 14.000 | 20.200 | 8.47 | 138.49% |
| 2023-06-06 | 5 | 25 | 14.000 | 20.200 | 6.24 | 223.72% |
| 2023-10-06 | 5 | 25 | 14.001 | 20.000 | 4.84 | 313.22% |
| 2023-11-10 | 5 | 25 | 14.001 | 20.000 | 5.34 | 274.53% |
PDSB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 35 weeks, PDSB's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how PDS BIOTECHNOLOGY CORP fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1712.47% of that group.
- PDSB has a higher number of analysts covering the stock than 415.41% of all US stocks.
- PDS BIOTECHNOLOGY CORP's average analyst price target is higher than 461.76% of all US stocks.
- PDSB has a lower variance in analysts' estimates than -1120.85% of stocks in the small market cap category.
Stocks similar to PDS BIOTECHNOLOGY CORP in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EPIX, VKTX, and ELDN.
View All Top Stocks by Price Target
Make investment decisions regarding PDSB using the data that counts. Try POWR Ratings for free.